BridgeBio Pharma LLC: SCHEDULE 13D filed Aug 18, 2025

Form type
SCHEDULE 13D
Filing date
Aug 18, 2025
Accession number
0001193125-25-182790
Filer
BridgeBio Pharma LLC (CIK 2076615)